Therefore, NAFLD patients carrying A instead of G allele at APOC3 rs2070667 may susceptible to hepatic inflammation upon the rs2070667-based alteration of serum TGs. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.